Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03 on Revenues of $11.6M

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03. Revenue for the quarter came in at $11.6 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• RenaissanceRe Holdings (RNR) PT Raised to $315 at TD Cowen
• ADNOC Distribution agrees to buy Shell's South Africa unit for $1B